Virtu Financial’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-65,436
Closed -$557K 2210
2025
Q1
$557K Buy
+65,436
New +$361K 0.03% 459
2024
Q3
Sell
-13,609
Closed -$12K 1993
2024
Q2
$12K Buy
+13,609
New +$12.9K ﹤0.01% 1115
2024
Q1
Sell
-29,376
Closed -$28K 2235
2023
Q4
$28K Buy
29,376
+5,986
+26% +$5.8K ﹤0.01% 1269
2023
Q3
$22K Buy
+23,390
New +$25.5K ﹤0.01% 1004
2023
Q1
Sell
-19,400
Closed -$36K 2204
2022
Q4
$36K Sell
19,400
-28,655
-60% -$56.1K ﹤0.01% 1147
2022
Q3
$93K Sell
48,055
-13,418
-22% -$30.1K 0.01% 1103
2022
Q2
$128K Buy
61,473
+48,020
+357% +$154K 0.01% 881
2022
Q1
$62K Buy
13,453
+2,547
+23% +$14.2K ﹤0.01% 1077
2021
Q4
$70K Buy
10,906
+665
+6% +$3.99K 0.01% 1248
2021
Q3
$63K Buy
+10,241
New +$70.4K 0.01% 1237
2020
Q3
Sell
-17,941
Closed -$56K 1614
2020
Q2
$56K Buy
+17,941
New +$46.4K 0.01% 990
2019
Q4
$46K Buy
+22,864
New +$42.1K ﹤0.01% 1217
2019
Q2
Sell
-10,423
Closed -$22K 1953
2019
Q1
$22K Buy
+10,423
New +$23.7K ﹤0.01% 1280
2017
Q4
Sell
-13,228
Closed -$69K 3124
2017
Q3
$69K Buy
+13,228
New +$65.1K ﹤0.01% 2166

Other funds holding CMRX

Virtu Financial's CMRX Position: Q2 2025 in Review

Virtu Financial sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 65,436 shares — an estimated $557K sold.

Virtu Financial first reported a position in CMRX in Q3 2017 and held it in 14 quarters. The position peaked at $557K in Q1 2025. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

  • Virtu Financial reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
  • Virtu Financial sold 65,436 Chimerix, Inc. shares in Q2 2025, an estimated $557K.
  • Virtu Financial first reported a position in Chimerix, Inc. in Q3 2017 and held it in 14 quarters.
  • Virtu Financial's Chimerix, Inc. position peaked at $557K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.